Home600664 • SHA
add
Harbin Pharmaceutical Group Co., Ltd.
Previous close
3.31
Day range
3.26 - 3.33
Year range
2.41 - 3.90
Market cap
8.34B
Avg Volume
53.12M
P/E ratio
17.90
Dividend yield
-
Primary exchange
SHA
Market news
CNBC
3 hours ago
Stock futures fall slightly after S&P 500 notches best week of the year:
Live updates
0.20%
Financials
Income Statement
Revenue
Net income
| (CNY) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 4.14B | 5.36% |
Operating expense | 951.29M | 20.76% |
Net income | 176.74M | 44.52% |
Net profit margin | 4.27 | 37.30% |
Earnings per share | — | — |
EBITDA | 287.09M | 8.95% |
Effective tax rate | 22.35% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.85B | 17.42% |
Total assets | 14.15B | 4.47% |
Total liabilities | 8.53B | 1.01% |
Total equity | 5.61B | — |
Shares outstanding | 2.52B | — |
Price to book | — | — |
Return on assets | 3.99% | — |
Return on capital | 7.56% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 176.74M | 44.52% |
Cash from operations | -270.80M | -248.28% |
Cash from investing | -14.74M | -2.78% |
Cash from financing | 126.27M | 100.85% |
Net change in cash | -159.44M | -168.95% |
Free cash flow | -487.18M | -1,808.96% |
About
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Founded
1988
Website
Employees
9,853
